Quetzal Therapeutics Appoints Todd Smith as Board Member
Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with $50 million of committed capital.
Quetzal Therapeutics Appoints Todd Smith as Board Member
Quetzal Therapeutics Appoints Todd Smith as Board Member